The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Updated clinical practice guidelines for the prevention and treatment of mucositis
Abstract
Considerable progress in research and clinical application has been made since the original guidelines for managing mucositis in cancer patients were published in 2004, and the first active drug for the prevention and treatment of this condition has been approved by the United States Food and Drug Administration and other regulatory agencies in Europe and Australia. These changes necessitate an updated review of the literature and guidelines. Panel members reviewed the biomedical literature on mucositis published in English between January 2002 and May 2005 and reached a consensus based on the criteria of the American Society of Clinical Oncology. Changes in the guidelines included recommendations for the use of palifermin for oral mucositis associated with stem cell transplantation, amifostine for radiation proctitis, and cryotherapy for mucositis associated with high‐dose melphalan. Recommendations against specific practices were introduced: Systemic glutamine was not recommended for the prevention of gastrointestinal mucositis, and sucralfate and antimicrobial lozenges were not recommended for radiation‐induced oral mucositis. Furthermore, new guidelines suggested that granulocyte–macrophage‐colony stimulating factor mouthwashes not be used for oral mucositis prevention in the transplantation population. Advances in mucositis treatment and research have been complemented by an increased rate of publication on mucosal injury in cancer. However, additional and sustained efforts will be required to gain a fuller understanding of the pathobiology, impact on overall patient status, optimal therapeutic strategies, and improved educational programs for health professionals, patients, and caregivers. These efforts are likely to have significant clinical and economic impact on the treatment of cancer patients. Cancer 2007;109:820–31. © 2007 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TROTTI, A., COLEVAS, A., SETSER, A., RUSCH, V, JAQUES, D., BUDACH, V, LANGER, C., MURPHY, B., CUMBERLIN, R., & COLEMAN, C. (2003) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(03)00031-6 · Cited by 2,569
Sonis, S. T., Elting, L. S., Keefe, D., Peterson, D. E., Schubert, M., Hauer-Jensen, M., Bekele, B. N., Raber-Durlacher, J., Donnelly, J. P., Rubenstein, E. B., et al. (2004) · Cancer · doi:10.1002/cncr.20162 · Cited by 1,417
Self-citationSonis, S. T. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1318 · Cited by 1,361
Self-citationPalifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
Spielberger, R., Stiff, P., Bensinger, W., Gentile, T., Weisdorf, D., Kewalramani, T., Shea, T., Yanovich, S., Hansen, K., Noga, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040125 · Cited by 893
Rubenstein, E. B., Peterson, D. E., Schubert, M., Keefe, D., McGuire, D., Epstein, J., Elting, L. S., Fox, P. C., Cooksley, C., Sonis, S. T., et al. (2004) · Cancer · doi:10.1002/cncr.20163 · Cited by 820
Self-citationSymptom Clusters: Concept Analysis and Clinical Implications for Cancer Nursing
Kim, H.-J., McGuire, D. B., Tulman, L., & Barsevick, A. M. (2005) · Cancer Nursing · doi:10.1097/00002820-200507000-00005 · Cited by 598
Self-citationCleeland, C. S., Bennett, G. J., Dantzer, R., Dougherty, P. M., Dunn, A. J., Meyers, C. A., Miller, A. H., Payne, R., Reuben, J. M., Wang, X. S., et al. (2003) · Cancer · doi:10.1002/cncr.11382 · Cited by 526
Braun, S., Hanselmann, C., Gassmann, M. G., auf dem Keller, U., Born-Berclaz, C., Chan, K., Kan, Y. W., & Werner, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5492-5505.2002 · Cited by 410
Symptom Clusters: The New Frontier in Symptom Management Research
Miaskowski, C. (2004) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgh023 · Cited by 403
Rating the quality of evidence for clinical practice guidelines
Hadorn, D. C., Baker, D., Hodges, J. S., & Hicks, N. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(96)00019-4 · Cited by 332
Epstein, J. B., Silverman, S., Paggiarino, D. A., Crockett, S., Schubert, M. M., Senzer, N. N., Lockhart, P. B., Gallagher, M. J., Peterson, D. E., & Leveque, F. G. (2001) · Cancer · doi:10.1002/1097-0142(20010815)92:4<875::aid-cncr1396>3.0.co;2-1 · Cited by 268
Self-citationOccurrence of Symptom Clusters
Dodd, M. J. (2004) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgh008 · Cited by 254
McGuire, D. B., Corrêa, M. E. P., Johnson, J. J., et al. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0051-8 · Cited by 153
Self-citationMeropol, N. J., Somer, R. A., Gutheil, J. C., Pelley, R. J., Modiano, M., Rowinsky, E. K., Rothenberg, M. L., Redding, S. W., Serdar, C. M., Yao, B., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.079 · Cited by 148
Jones, J. A., Avritscher, E. B. C., Cooksley, C. D., Michelet, M., Bekele, B. N., & Elting, L. S. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0055-4 · Cited by 147
Self-citationPeterson, D. E., Jones, J. B., & Petit, R. G. (2006) · Cancer · doi:10.1002/cncr.22384 · Cited by 134
Self-citationAthanassiou, H., Antonadou, D., Coliarakis, N., Kouveli, A., Synodinou, M., Paraskevaidis, M., Sarris, G., Georgakopoulos, G., Panousaki, K., Karageorgis, P., et al. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00187-1 · Cited by 117
Pytlík, R., Beneš, P., Pat'orková, M., Chocenská, E., Gregora, E., Procházka, B., & Kozák, T. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703759 · Cited by 108
Are inflammatory cytokines the common link between cancer-associated cachexia and depression?
Illman, J., Corringham, R. E., Robinson, D., Davis, H. M., Rossi, J., Cella, D. F., & Trikha, M. (2005) · PubMed · Cited by 95
Barriers and strategies in implementation of oral care standards for cancer patients
McGuire, D. B. (2003) · Supportive Care in Cancer · doi:10.1007/s00520-003-0466-4 · Cited by 80
Self-citationEl-Sayed, S. M., Nabid, A., Shelley, W. E., Hay, J. R., Balogh, J. M., Gelinas, M., MacKenzie, R., Read, N. E., Berthelet, E., Lau, H., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.046 · Cited by 75
Self-citationAssessment and measurement of oral mucositis
Eilers, J., & Epstein, J. B. (2004) · Seminars in Oncology Nursing · doi:10.1053/j.soncn.2003.10.005 · Cited by 71
Self-citationFreytes, C. O., Ratanatharathorn, V., Taylor, C., Abboud, C. N., Chesser, N., Restrepo, A., Arango, J. I., & Odenheimer, D. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1118 · Cited by 69
Amifostine as Radioprotective Agent for the Rectal Mucosa during Irradiation of Pelvic Tumors
Kouvaris, J., Kouloulias, V., Mallas, E., Antypas, C. E., Kokakis, J. D., Michopoulos, S., Matsopoulos, G. K., & Vlahos, L. J. (2003) · Strahlentherapie und Onkologie · doi:10.1007/s00066-003-0970-y · Cited by 52
New thoughts on the pathobiology of regimen-related mucosal injury
Anthony, L. B., Bowen, J. M., Garden, A. S., Hewson, I., & Sonis, S. T. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0058-1 · Cited by 48
Self-citationIntrarectal application of amifostine for the prevention of radiation-induced rectal injury
Ben‐Josef, E., Han, S. J., Tobi, M., Vargas, B., Stamos, B., Kelly, L., Biggar, S., & Kaplan, I. D. (2002) · Seminars in Radiation Oncology · doi:10.1053/srao.2002.31379 · Cited by 46
Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls
Keefe, D. M. K., Peterson, D. E., & Schubert, M. M. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0059-0 · Cited by 26
Self-citationMucositis guidelines: what have they achieved, and where to from here?
Keefe, D. M. K. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0056-3 · Cited by 22
Self-citationAlimentary mucositis: putting the guidelines into practice
Brennan, M. T., Bültzingslöwen, I. V., Schubert, M. M., & Keefe, D. M. K. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0054-5 · Cited by 15
Self-citation
Cited by
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
Stewart, F. A., Akleyev, A. V., Hauer-Jensen, M., Hendry, J. H., Kleiman, N. J., MacVittie, T. J., Aleman, B. M., Edgar, A. B., Mabuchi, K., Muirhead, C. R., et al. (2012) · Annals of the ICRP · doi:10.1016/j.icrp.2012.02.001 · Cited by 1,604
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
Elad, S., Cheng, K. K. F., Lalla, R. V., Yarom, N., Hong, C., Logan, R. M., Bowen, J., Gibson, R., Saunders, D. P., Zadik, Y., et al. (2020) · Cancer · doi:10.1002/cncr.33100 · Cited by 1,336
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
Lalla, R. V., Bowen, J., Barasch, A., Elting, L., Epstein, J., Keefe, D. M., McGuire, D. B., Migliorati, C., Nicolatou‐Galitis, O., Peterson, D. E., et al. (2014) · Cancer · doi:10.1002/cncr.28592 · Cited by 1,110
Self-citationGut microbiota modulation of chemotherapy efficacy and toxicity
Alexander, J. L., Wilson, I. D., Teare, J., Marchesi, J. R., Nicholson, J. K., & Kinross, J. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.20 · Cited by 970
“However, there remains a paucity of effective interventions to prevent gastrointestinal toxicity or mitigate against its symptoms 41 .”
Metadata
- Authors
- Keefe, D. M., Schubert, M. M., Elting, L. S., Sonis, S. T., Epstein, J. B., Raber‐Durlacher, J. E., Migliorati, C. A., McGuire, D. B., Hutchins, R. D., & Peterson, D. E.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2007-02-22
- Volume
- 109
- Issue
- 5
- Pages
- 820-831
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2067089217
- Cited by
- 784
- References
- 29
- FWCI
- 42.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.